High expression of the CDX2 gene in CRC is linked to a 50% lower death rate compared to cases where it is low or absent, and its proper functioning enhances survival rates without disease progression or tumor recurrence [7,35]. This evidence concerns the gene CDX2 and colorectal carcinoma.